Skip to content

Acadia Pharmaceuticals Inc.

/ ACADNMS

What is ACAD stock?

ACAD is the U.S. stock ticker for Acadia Pharmaceuticals Inc..

As of 2026-07-29: price $26.34; market cap $4.45B; latest earnings 2026-05-06; 12 recent 13F changes.

$26.34+1.27%

Yahoo Finance·Updated 07/29/2026, 10:43 PM UTC

Current price
$26.34

Yahoo Finance

Market cap
$4.45B

Polygon.io

Latest earnings date
May 06, 2026

Nasdaq

Data status
Current

Source: Yahoo FinancePolygon.ioNasdaq earnings historyUpdated: 07/29/2026, 10:43 PM UTC

Price change after earnings

After 1 day

+5.03%

$21.48$22.56

May 06, 2026May 07, 2026

After 7 days

+3.26%

$21.48$22.18

May 06, 2026May 13, 2026

After 30 days

+0.37%

$21.48$21.56

May 06, 2026Jun 05, 2026

Before-market or after-market timing is unavailable.

Reported date confirmed

Recent insider transactions

Unavailable

13F institutional changes

Share counts are derived from reported value divided by the filing price and are rounded for display.

Key people timeline

  1. Catherine Owen Adams

    Acadia delivered a solid first quarter of 2026 with total revenues of $268 million, driven by a strong start from DAYBUE, which generated sales of $101 million

    Acadia Pharmaceuticals Inc. (ACAD)

Data sources and methodology

Prices use Yahoo Finance, earnings dates use Nasdaq, and company reference data prefers Polygon.io. When Polygon market cap is unavailable, the page derives it from the latest SEC shares outstanding multiplied by the Yahoo price. Insider and institutional records link to SEC EDGAR, and missing values are never invented.

Updated: 07/29/2026, 10:43 PM UTC

Yahoo Finance
07/29/2026, 10:43 PM UTC
Polygon.io
07/29/2026, 10:42 PM UTC
Nasdaq earnings history
05/06/2026, 11:50 PM UTC
SEC Form 4
Unavailable
SEC 13F
06/09/2026, 02:33 PM UTC
Statements / public records
07/29/2026, 08:20 PM UTC